Three founders of Eucalyptus, the telehealth corporate known for prescribing semaglutide at scale, have accrued fortunes of $52 million each, according to the Australian Financial Review’s annual Young Rich List.

Charlie Gearside and Tim Doyle, both 34, worked at multimillion-dollar mattress company Koala before launching Eucalyptus in 2019, alongside chief strategy officer Benny Kleist, 33.